The results of COX regression analysis indicated that the levels of HOTAIR in tumor tissue and peripheral blood were independent predictive factors of OS and PFS in patients with advanced HCC who were treated with Sunitinib. This evidence concerns the gene HOTAIR and hepatocellular carcinoma.